REMOVAL: Mixed Data on CV Benefits of Metformin in Type 1 Diabetes REMOVAL: Mixed Data on CV Benefits of Metformin in Type 1 Diabetes

Results from REMOVAL trial suggest possible cardiovascular benefit, but minimal effect on glucose lowering, in type 1 diabetes patients at increased cardiovascular risk.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news